Drug study for depression in people with cancer
Part of Mental health clinical trials.
This early-stage study tests PDC-1421 to treat moderate to severe depression in people who have cancer and have recently had treatment like chemotherapy and/or radiation. If you’re experiencing ongoing depressive symptoms, the study aims to see whether this medication is safe and helpful for your mood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 21 and 85 years old
- Have been diagnosed with cancer (stage I, II, or III) and confirm it with pathology results (biopsy/surgery)
- Have had cancer treatment with radiation and/or chemotherapy during the past year (or are currently receiving it)
- Have depression symptoms for at least 2 weeks and score high enough on a depression questionnaire (MADRS 20 or higher)
- Not be at high immediate risk of harming yourself and not need urgent psychiatric hospitalization
- Be able to take pills by mouth and complete study visits in English without extra help
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called NBI-1065845 added to your current antidepressant. It is for people with moderate to severe depression or persistent depressive disorder who have not improved enough with oral antidepressants alone.
This study tests an investigational drug called BMS-986511 in adults with moderate to severe depression. The goal is to see if it can improve symptoms.
This trial tests an investigational medication for adults with major depressive disorder who are currently taking an antidepressant but still have symptoms. It aims to see if adding this new drug can improve mood better than a placebo.
This trial tests an experimental oral medication, SPT-300, for people with major depressive disorder, even if they also have mild anxiety. The goal is to see if it helps improve mood safely.
This trial tests whether a single dose of psilocybin, a psychedelic medication, can safely and effectively treat major depression in people with cancer. If you have cancer and have been feeling depressed for at least a month, you may qualify.
This study tests a new detection method for depression in people with breast cancer. It uses samples like blood, stool, and saliva to find a link between breast cancer and depression.
Hear when a new Major Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.